Pharmagreen Biotech Inc. Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from Q4 2020 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
Pharmagreen Biotech Inc. quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from Q4 2020 to Q4 2022.
  • Pharmagreen Biotech Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending December 31, 2022 was -$51.5K, a 417% decline year-over-year.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 -$51.5K -$67.7K -417% Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-14
Q2 2022 $293K +$448K Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-17
Q1 2022 -$1.05M +$2.1M +66.6% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $16.3K +$476K Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q2 2021 -$155K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-17
Q1 2021 -$3.15M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$460K Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.